Pilot Study of the Efficacy & Safety of Natural Eggshell Membrane (NEM) for Joint & Connective Tissue Disorders

About this trial

Last updated 3 years ago

Study ID

CLN# A0803

Status

Completed

Type

Interventional

Phase

N/A

Placebo

Accepting

18 to 100 Years

All Sexes

Trial Timing

Ended 22 years ago

What is this trial about?

The purpose of this study was to evaluate the use of the dietary supplement Natural Eggshell Membrane (NEM) for the treatment of joint and connective tissue discomfort, pain, and flexibility.

What are the participation requirements?

Inclusion Criteria

* patients seeking relief of mild to moderate pain due to joint or connective tissue (JCT)disorders.

* subjects must have had persistent pain associated with a JCT disorder.

* subjects were required to suspend all current pain relief medications.

* Subjects that were currently taking analgesic medications were eligible to participate in the studies following a 14 day washout period for NSAIDs, a 7 day washout for narcotics, and a 90 day washout for injected steroids.

* subjects currently taking glucosamine, chondroitin sulfate or MSM were only eligible after a 3-month washout period.

Exclusion Criteria

* Patients were excluded if they were currently receiving remission-inducing drugs such as methotrexate or immunosuppressive medications or had received them within the past 3 months.

* body weight 250 pounds or greater.

* a known allergy to eggs or egg products.

* pregnant or breastfeeding women.

* subjects previously enrolled in a study to evaluate pain relief within the past 6 months or currently involved in any other research study involving an investigational product (drug, device, or biologic) or a new application of an approved product, within 30 days of screening.